Inflammatory acne is the pattern dominated by red, inflamed papules and pustules. Inflammation turns a blocked pore into a red pimple, and this pattern is far more likely to scar than comedonal acne. Treatment is staged — prescription topicals first-line, short courses of oral antibiotics for moderate disease, PDT and laser for selected patients.
- Inflammatory acne is the pattern dominated by red, inflamed papules and pustules rather than blackheads and whiteheads.
- Inflammation is what turns a blocked pore into a red pimple — immune pathways raise inflammatory cytokines including IL-1.
- Inflammatory acne is far more likely to scar than purely comedonal acne, so early effective treatment is the priority.
- If the follicle wall ruptures, inflammation spills into deeper skin and forms a nodule, increasing scarring risk.
- First-line is prescription topical therapy — a topical retinoid with benzoyl peroxide and/or a topical antibiotic.
- Short courses of doxycycline or minocycline are added for moderate disease, with topical therapy, to limit resistance.
- Photodynamic acne therapy and adjunctive laser or LED options help selected patients who cannot tolerate or have failed first-line therapy.
- One treatment tier gets 8–12 weeks of consistent use before stepping up to the next.
- Brown marks (PIH) and red marks (PIE) commonly follow inflammation and need their own targeted strategies.
- Rosacea also causes facial inflammatory bumps but usually without blackheads — and many acne treatments worsen it, so diagnosis matters.
Inflammatory Acne
Inflammatory acne is the pattern dominated by red, inflamed papules and pustules rather than blackheads and whiteheads. Inflammation is what turns a blocked pore into a red pimple, and it is what makes this pattern matter: inflammatory acne is far more likely to scar than purely comedonal acne, and it is more likely to leave brown or red marks behind. Treatment is doctor-led and stepped — prescription topicals first, oral antibiotics added for moderate disease — and the reason to start early is that scarring is irreversible.
By Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA
Last reviewed 2026-07-26 · Editorial policy
Inflammatory acne is the pattern dominated by red, inflamed papules and pustules rather than blackheads and whiteheads. Inflammation is what turns a blocked pore into a red pimple — and this pattern is far more likely to scar than purely comedonal acne, which is why it warrants earlier, doctor-led treatment. (1)
What inflammatory acne looks like
Red, inflamed papules and pustules on the face, chest, back and jawline, usually tender to touch, often on a background of redness. Blackheads and whiteheads may still be present, but they are not the dominant feature.
When lesions settle they frequently leave marks behind — brown marks (post-inflammatory hyperpigmentation) or red marks (post-inflammatory erythema) — and where inflammation has been deep or prolonged, scars.
Why inflammation matters
Inflammation is what turns a blocked pore into a red pimple. Cutibacterium acnes and follicle contents can activate immune pathways that increase inflammatory cytokines (including IL-1) and recruit inflammatory cells. (3,4,5)
Some studies show inflammatory and tissue-remodelling genes increase in acne lesions, which helps explain why deep, prolonged inflammation increases the risk of scarring. (6)
C. acnes is a normal part of skin flora — acne is not simply an infection. What appears to matter is dysbiosis (an imbalance) and differences between bacterial strains, and acne-related strains may stimulate stronger inflammatory immune responses, including pathways linked with IL-17. (2,3)
If the follicle wall ruptures, inflammation can spill into the deeper skin and form a nodule, increasing scarring risk. (1)
Scarring — why early treatment is the whole point
Inflammatory acne is more likely to scar than purely comedonal acne. Scars can be atrophic (ice-pick, rolling, boxcar) or hypertrophic/keloid (more common on chest, back and jawline in predisposed patients). (1)
Early effective treatment is the single most important factor in preventing them. Treating inflammation early, avoiding picking, and stepping up therapy when first-line is not working are the proven strategies. Scarring is irreversible — prevention is far easier than treatment.
How inflammatory acne is treated
Treatment is staged, and the tier is matched to severity. (1)
- Prescription topical therapy — topical retinoids (adapalene, tretinoin) combined with benzoyl peroxide and/or topical antibiotics for mild-to-moderate acne. First-line evidence-based treatment.
- Oral antibiotics — short courses of doxycycline or minocycline for moderate inflammatory acne, used in combination with topical therapy to limit resistance.
- Photodynamic Acne Therapy (PDT) — a light-activated treatment that targets sebaceous glands and Cutibacterium acnes. Useful in selected patients who cannot tolerate or have failed first-line therapy.
- Laser and light therapy — adjunctive laser and LED options for inflammatory acne and post-acne marks.
Our prescription acne treatments guide → covers each tier in detail, and LED vs laser vs PDT for acne → compares the light-based options.
What it leaves behind
- Post-inflammatory hyperpigmentation (brown marks). Common after inflammation, especially in darker skin types, and may persist for months without treatment — see post-inflammatory hyperpigmentation →.
- Post-inflammatory erythema (red marks). Persistent redness can remain after acne lesions heal and may respond to targeted vascular strategies in selected cases.
- Scarring. If scarring is your main concern, see acne scarring treatments →.
When it might not be inflammatory acne
Rosacea → also produces inflammatory bumps on the face, but it usually starts in adulthood with persistent background redness, flushing and visible vessels — and bumps without blackheads. Many acne treatments (aggressive cleansers, benzoyl peroxide, strong retinoids) can worsen rosacea, so accurate diagnosis matters. Peri-orificial dermatitis → causes a bumpy rash around the mouth, nose or eyes, often worsened by topical steroids.
When to see a doctor
See a doctor early if acne is inflammatory or starting to scar. Also seek review if marks are being left behind, if there is a jawline or cyclical pattern suggesting hormonal involvement →, if your skin is causing significant distress at any severity, or if a structured over-the-counter routine has not worked after 8–12 weeks.
This page covers one pattern. For the full picture see our acne hub →; if your acne is mostly blackheads and whiteheads see comedonal acne →, and if you have deep, tender lumps see nodulocystic acne →.
Symptoms
- Red, inflamed papules and pustules
- Tenderness or soreness of individual lesions
- Background redness around active lesions
- Brown marks (post-inflammatory hyperpigmentation) or red marks (post-inflammatory erythema) after lesions settle
- Commonly on the face, chest, back and jawline
Causes & contributors
- Inflammation and immune activation — the defining driver of this pattern
- Follicular plugging (hyperkeratinisation)
- Increased oil (sebum) production
- Changes in the follicle microbiome, especially Cutibacterium acnes
Diagnosis
Inflammatory acne is diagnosed clinically by a doctor. Assessment grades severity (mild, moderate, severe) and identifies the predominant lesion type — comedonal, inflammatory or nodulocystic — because that is what determines the right starting treatment and how quickly it needs to be escalated. Because inflammatory acne is far more likely to scar than purely comedonal acne, the assessment also weighs scarring risk and whether marks are already being left behind.
Treatment options
Prescription topical therapy
Topical retinoids (adapalene, tretinoin) combined with benzoyl peroxide and/or topical antibiotics for mild-to-moderate acne. First-line evidence-based treatment.
Oral antibiotics
Short courses of doxycycline or minocycline for moderate inflammatory acne, used in combination with topical therapy to limit resistance.
Photodynamic Acne Therapy (PDT) →
A light-activated treatment that targets sebaceous glands and Cutibacterium acnes. Useful in selected patients who cannot tolerate or have failed first-line therapy.
Laser and light therapy →
Adjunctive laser and LED options for inflammatory acne and post-acne marks. Discussed in our LED vs Laser vs PDT comparison.
When to see a doctor
See a doctor early if acne is inflammatory or starting to scar — scarring is irreversible and prevention is far easier than treatment. Significant emotional distress at any severity, acne leaving brown or red marks, a jawline or cyclical pattern suggesting hormonal involvement, and acne that is not responding to a structured over-the-counter routine after 8–12 weeks are all reasons to seek doctor-led care.
Frequently asked questions
-
What is inflammatory acne?
Inflammatory acne is the pattern dominated by red, inflamed papules and pustules rather than blackheads and whiteheads. Inflammation is what turns a blocked pore into a red pimple — Cutibacterium acnes and follicle contents can activate immune pathways that increase inflammatory cytokines (including IL-1) and recruit inflammatory cells. It matters because inflammatory acne is far more likely to scar than purely comedonal acne. -
Why does inflammatory acne scar more than blackheads and whiteheads?
Inflammatory acne is more likely to scar than purely comedonal acne because the damage is deeper. If the follicle wall ruptures, inflammation can spill into the deeper skin and form a nodule, increasing scarring risk. Studies also show inflammatory and tissue-remodelling genes increase in acne lesions, which helps explain why deep, prolonged inflammation increases the risk of scarring. Early effective treatment is the single most important factor in preventing scars. -
How is inflammatory acne treated?
Treatment is staged. Prescription topical therapy is first-line — a topical retinoid (adapalene, tretinoin) combined with benzoyl peroxide and/or topical antibiotics. For moderate inflammatory acne, short courses of doxycycline or minocycline are added, used in combination with topical therapy to limit resistance. Photodynamic acne therapy and adjunctive laser or LED options are useful in selected patients who cannot tolerate or have failed first-line therapy. -
Why are oral antibiotics only given in short courses?
Short courses of doxycycline or minocycline are used for moderate inflammatory acne, in combination with topical therapy, to limit antibiotic resistance. Benzoyl peroxide is a key partner for this reason. The aim is to bring inflammation under control and then maintain that control with topical therapy rather than to stay on an antibiotic indefinitely. -
Will inflammatory acne leave marks?
It can. Post-inflammatory hyperpigmentation (brown marks) is common after inflammation, especially in darker skin types, and may persist for months without treatment. Post-inflammatory erythema (red marks) is persistent redness that can remain after lesions heal and may respond to targeted vascular strategies in selected cases. These marks are not scars, but they need their own targeted strategies. -
Could my inflammatory bumps be rosacea rather than acne?
They could. Rosacea also produces inflammatory bumps on the face, but it usually starts in adulthood, with persistent background redness, flushing and visible vessels — and bumps without blackheads. Many acne treatments, including aggressive cleansers, benzoyl peroxide and strong retinoids, can worsen rosacea, so the distinction changes the treatment. Accurate diagnosis matters.
References
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33.
- O'Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome. 2018;6:177.
- Agak GW, Qin M, Nobe J, et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol. 2014;134(2):366–373.
- Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535–1541.
- Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 2014;134(11):2747–2756.
- Trivedi NR, Gilliland KL, Zhao W, et al. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol. 2006;126(5):1071–1079.
Related
Related conditions
Medically reviewed by Dr Christopher Irwin, MBChB, FRACGP, MMed (Skin Cancer), FACAM, MSCCA · Last reviewed 2026-07-26 · Editorial policy